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Galactosaminogalactan (GAG) is an insoluble aminosugar polymer produced by
Aspergillus fumigatus and has anti-inflammatory properties. Here, the minimum
glycosidic sequences required for the induction of IL-1Ra by peripheral blood
mononuclear cells (PBMCs) was investigated. Using chemical degradation of native GAG
to isolate soluble oligomers, we have found that the de-N-acetylation of galactosamine
residues and the size of oligomer are critical for the in vitro immune response. A minimal
oligomer size of 20 galactosamine residues is required for the anti-inflammatory response
but the presence of galactose residues is not necessary. In a Dextran sulfate induced
colitis mouse model, a fraction of de-N-acetylated oligomers of 13 < dp < 20 rescue
inflammatory damage like the native GAG polymer in an IL-1Ra dependent pathway. Our
results demonstrate the therapeutic suitability of water-soluble GAG oligosaccharides
in IL-1 mediated hyper-inflammatory diseases and suggest that α-1,4-galactosamine
oligomers chemically synthesized could represent new anti-inflammatory glycodrugs.
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INTRODUCTION
The galactosaminogalactan (GAG) is a polysaccharide produced by the human fungal pathogen,
Aspergillus fumigatus which is a major virulence factor for this fungal species. GAG mediates the
adherence of mycelium to abiotic or host-cell surfaces within biofilm and protects the fungus
against host-cell damages (Gravelat et al., 2013; Beaussart et al., 2015; Lee et al., 2015). In mouse
model of aspergillosis, intra-nasally administration of GAG promotes fungal infection and directly
affects the innate immune response resulting in an inhibition of the protective T-helper (Th) 1
and regulatory T cells (Treg) as well as a promotion of Th2 responses (Fontaine et al., 2011).
In addition, GAG induces apoptosis in neutrophils (Robinet et al., 2014). GAG did not induce
any of the proinflammatory cytokines TNFα, IL-6, IL-8, IFNγ, IL-17, and IL-9 neither the anti-
inflammatory cytokine IL-10 (Gresnigt et al., 2014). However, GAG reduced the production of
Th cytokines IL-17, IL-22, and IFNγ in Aspergillus stimulated PBMCs. Most importantly, GAG
inhibits the IL-1 bioactivity by the induction of the production of high amounts of IL-1 receptor
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antagonist (IL-1Ra) (Gresnigt et al., 2014). The capacity of
GAG to induce IL-1Ra is responsible for its potent anti-
inflammatory properties favoringAspergillus infections (Gresnigt
et al., 2014). The anti-inflammatory potential of GAG has
been also shown in experimental dextran sodium sulfate (DSS)-
induced colitis in mice with chronic granulomatous disease
(CGD). The intraperitoneal administration of GAG resulted in
the improvement of clinical signs of colitis and of inflammatory
lesions in both wild-type and CGD mice. The effects of GAG
on CGD colitis were similar to those of IL-1Ra administration
(Gresnigt et al., 2014), making it a potent alternative to tackle
chronic inflammatory diseases.
GAG is a linear heterogeneous highmolecular weight polymer
with an average size of 100 kDa and it is composed of α-
1,4-linked galactopyranose (Galp), α-1,4-linked galactosamine
(GalNH2), and α-1,4-linked N-acetylgalactosamine (GalNAc)
residues. Monosaccharides are randomly distributed along the
chain (Fontaine et al., 2011; Lee et al., 2016). Due to the
heterogeneity of the molecule and the absence of clear repeating
unit, the oligosaccharides responsible for the immunological
functions of GAG are unknown. It has been only shown that the
deacetylation of the GAG is essential for the adherence and the
virulence of the fungus (Lee et al., 2016). However, the degree
of acetylation and the size of the oligosaccharide responsible for
the anti-inflammatory properties of GAG were unknown to date.
For this purpose, we have isolated water-soluble oligomers that
are inducers of IL-1Ra and shown that long water-soluble de-
N-acetylated galactosamine oligomers of 13 < DP < 20 rescue
inflammatory damage similarly as the GAG polymer in an IL-1Ra
dependent pathway.
MATERIALS AND METHODS
Cultivation and GAG Purification
A. fumigatus strain Dal (CBS144-89) was cultivated on malt-agar
tubes for 3 days at 37◦C. Conidia were collected with 4ml 0.05%
tween20 and vortexing of the tube. The conidia suspension was
stored up to 3 weeks at 4◦C.
GAG isolation and purification was carried out as previously
described (Fontaine et al., 2011). Briefly, 100ml Brian medium
was inoculated with a final concentration of 5 × 105 conidia per
ml in 150ml Erlenmeyer flasks. After cultivation for 3 days at
37◦C and 170 rpm, the pooled supernatant of 20 cultures was
collected by filtration and was adjusted to pH 3 by addition of 100
µl 12M HCl per 100ml supernatant. Two volumes of precooled
ethanol (4◦C) were added and GAG was precipitated for 3 h at
4◦C. The precipitate was collected by centrifugation for 20min
at 5,000 g at 4◦C and subsequently washed twice with 1/10 of
the culture volume of 100mM NaCl for 1 h under agitation (100
rpm). GAG was dialyzed against tap water and twice against
purified water (24 h each) and finally lyophilized to dryness and
stored at ambient temperature.
Chemical Modification of Polysaccharides
De-N-Acetylation of Polysaccharides
GAG was suspended in 3ml of 10mM HCl at a final
concentration of 3.33 mg/ml by sonication in plastic tubes. The
de-N-acetylation was started by addition of 3.4ml 18.8M NaOH
and the mixture was incubated at 100◦C for up to 4–5 h. The
tubes were vortexed every hour. The reaction was stopped on ice
and neutralization with 12M HCl. The mixture was buffered by
20mMTris, pH 7. De-N-acetylated GAGs (dGAG) were dialyzed
against tap water and twice against dH20 (24 h each) and finally
lyophilized to dryness and stored at ambient temperature.
Acetylation of Oligosaccharides
The acetylation procedure described by Lavertu et al. (2012)
was modified as following: 0.5mg dGAG oligosaccharides (F-
I and F-III) were lyophilized to dryness and were solved in 25
µl of 400mM acetic acid and 100 µl CH3OH. The mixture
was preincubated for 1 h at ambient temperature under agitation
at 300 rpm. Acetylation was initiated by addition 3 µl acetic
anhydride. After 1 h of incubation, solvents were evaporated in
a desiccator overnight. The samples were desalted by repeated
dissolution with 500 µl water (4 times) followed by evaporation
to dryness. Samples were solved in 500µl water and finally stored
at−20◦C.
Production of GAG Oligosaccharides
De-N-acetylated GAG (dGAG) was hydrolyzed by 2M HCl at
100◦C for 1.5, 3, and 4.5 h. Preliminary assays showed that
1.5 and 3 h were optimal for generating oligosaccharides of
different sizes (DP 3–26). HCl was immediately evaporated after
hydrolysis by drying the oligosaccharidemixture overnight under
vacuum in presence of NaOH pellets. Soluble oligosaccharides
were dissolved in 1ml of 150mM ammonium acetate, pH
4.5 and unsolved particles were removed by centrifugation
(3min, 17,000 g). The oligosaccharides were subjected to size
exclusion chromatography (SEC) on a Superdex 30 column
(GE Healthcare, 10 × 750mm) equilibrated with 150mM
ammonium acetate, pH 4.5 as described (Hamer et al., 2015).
The oligosaccharides were separated at a flow rate of 0.5 ml/min
and detected by the Gilson 132 RI detector. The osamine amount
of each fraction was determined by 3-methyl-2-benzothiazolinon
hydrazone hydrochloride hydrate assay (MBTH, see below). In
total eight 8 ml-fractions were obtained by pooling four 2 ml-
fractions per gel permeation assays and were named as F-I to
F-VIII (Figure S1). The fractions were desalted by lyophilization
for 2–3 days, addition of 1ml water and subsequent second
lyophilization overnight in a Savant speed vac concentrator. The
samples were resolved in 400 µl water and stored at−20◦C.
Analytical Procedures
MBTH Assay
De-N-acetylated osamines were detected and quantified by the
MBTH assay (Plassard et al., 1982). The procedure was carried
out in a 96 well plate (Sarstedt): 40 µl sample (containing up to
200 µg osamines/ml) were mixed with 40 µl 5 % KHSO4 (Sigma
Aldrich). The samples were reduced by addition of 40 µl 5%
NaNO2 (Sigma Aldrich) for 60min at 50
◦C, whereby 40 µl 5%
NaCl were used as negative control. After neutralization with 40
µl 12.5% NH4SO2NH2 (Sigma Aldrich) (ambient temperature,
30 rpm, 10min), 40 µl 0.5% 3-Methyl-2-benzothiazolinon
hydrazine hydrochloride hydrate (Sigma Aldrich) was added.
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The covered plate was incubated at 37◦C for 30min. Finally,
40 µl 0.5% FeCl3 was added and the absorption at λ = 650 nm
was measured by the Tecan infinite M200Pro ELISA plate reader,
while λ= 800 nm served as a reference wavelength. A calibration
curve of a serial dilution of D-galactosamine (GalN) served as
reference. To quantify the total amount of osamine or the degree
of acetylation (DA), a hydrolysis step was performed prior the
MBTH assay. Samples were totally hydrolyzed by 4M HCl at
100◦C for 4 h and subsequently dried overnight in a desiccator.
Acetate Assay
The DA was also estimated by the enzymatic acetate assay.
Samples (220 µl) were totally hydrolyzed by addition of 100 µl
12M HCl (100◦C, 4 h). Then, 100 µl were used for the osamine
detection by MBTH assay as described above and another 100 µl
were used for the acetate assay. After neutralization by addition
of 75 µl 7M NaOH and 75 µl 2MMOPS (pH 7.5), samples were
subjected to the Acetate Colorimetric Assay (Sigma-Aldrich)
according the manufacturer’s protocol. The absorption at λ =
450 nmwasmeasured by the Tecan infiniteM200Pro ELISA plate
reader, while λ = 700 nm served as a reference wavelength. The
acetate content in the hydrolyzed samples was determined by a
calibration curve of 0.25–1.5mM acetate standard solution.
Monosaccharide Identification and Quantification by
Gas Chromatography
Samples (100 µg) were hydrolyzed in 500 µl 8M HCl for
hexosamine analysis or 4M TFA for hexose analysis. Meso-
inositol (4 µg) was used as internal standard and 50 µg Gal,
GalNAc, and GlcNAc as external standards. After hydrolysis,
reduction with BH4Na and acetylation samples were analyzed by
GC on a Perichrom PR2100 instrument with a flame ionization
detector using a capillary column (30m × 0.32mm) filled with a
DB-1 (SGE) as described previously (Fontaine et al., 2011).
Enzymatic Degradation of GAG Fractions
Production of a Recombinant
Endo-α-1,4-Galactosaminidase
For the enzymatic degradation of GAG, a poly-GalN hydrolase
of Pseudomonas sp. (Tamura et al., 1988), here named GAGnase,
was produced in Escherichia coli. Prior to the total synthesis
of the gene, the DNA sequence was codon-optimized for
expression in E. coli. In addition, a histidine tag was added
to the carboxyl terminus to facilitate subsequent purification
(Figure S2). The gene was cloned into the pET28a (+) expression
vector and transformed into the E. coli BL21 Gold expression
strain. A culture in the exponential growth phase was induced
with 1mM IPTG (final concentration), followed by production
for 4 h at 30◦C. The protein could be found in the culture
supernatant (it contains a signal of bacterial secretion), the
cytoplasm and in the inclusion bodies. The enzyme present
in the supernatant was purified using ProBondTM Nickel-
chelating agarose beads (ThermoFisher) (ratio 0.5ml beads/50ml
supernatant) (Figure S2). The final preparation was kept in a
20mM HEPES buffer pH 7.4, 137mM NaCl and stored in
aliquots at−20◦C.
Enzymatic Degradation of Oligosaccharides
The enzymatic hydrolysis of GAG was carried out as previously
described (Tamura et al., 1992). In brief, 5 mg/ml GAG/dGAG or
1 mg/ml GAG oligosaccharides were dissolved in 50mM NaAc,
pH 6.0. The reaction (100 µl scale) was started by addition of
2µg/ml GAGnase and further incubated for 2 h at 37◦C. The
GAGnase was quickly heat-inactivated (100◦C, 5min) and the
degradation efficiency was estimated by the sugar reducing end
assay using the PABA as reagent (Lever, 1972).
MALDI-TOF Mass Spectrometry
MALDI-TOF spectra were analyzed in reflectron positive mode
using a 4800 TOF/TOF spectrometer (Applied Biosystems,
Framingham, MA, USA) equipped with a pulsed nitrogen laser
(337 nm and frequency of 200Hz). An average of 5,000 shots per
spot was used for MS data acquisition. Samples were prepared by
mixing directly on the target 0.5 µl of oligosaccharide solution
in water (10–50 pmol) with 0.5 µl of 2,5-dihydroxybenzoic acid
matrix solution (10 mg/ml in CH3OH/H2O, 50:50, V/V). The
samples were dried at room temperature.
Isolation of Peripheral Blood Mononuclear
Cells (PBMC)
Blood samples from healthy donors were obtained from
Etablissement Français du Sang Saint-Louis (Paris, France) with
written informed consent as per the guidelines provided by
the Institutional Ethics Committee, Institut Pasteur (convention
12/EFS/023). Human blood sample from healthy patients was
diluted 1:1 with PBS (Gibco). In a 50ml falcon tube, 15ml of
lymphocytes separation medium (Eurobio) were slowly overlaid
by 30ml of the blood dilution. The cells were separated by
centrifugation at ambient temperature (20min, 1800 rpm). The
upper phase (buffer and plasma) was discarded and the PBMCs
(2–5ml) were collected. The cells were washed by addition of
40ml PBS and subsequent centrifugation at ambient temperature
(10min, 1,500 rpm). The wash step was repeated (30ml PBS;
10min, 1200 rpm). The cells were finally suspended in 10–
20ml RPMI 1640 + Glutamax-I (Gibco) and counted in a
hemocytometer (c-Chip DHC-M01; Digital Bio). The cells were
finally diluted to a concentration of 1× 107 cells/ml in RPMI and
stored on ice.
Detection of Interleukin Production in
PBMCs by Enzyme-Linked Immunosorbent
Assay (ELISA)
PMBCs were seeded in a final concentration of 5 × 105 cells
in 200 µl RPMI 1640 + Glutamax-I supplemented with 10%
human serum in a U-shape 96 well plate. Native and de-N-
acetylated GAGs were tested in a final concentration 0.5, 1, and
5µg/ml (according to the MBTH assay). All de-N-acetylated
and per-N-acetylated oligosaccharides have been tested in a final
concentration of 1, 5, 10, and 25µg/ml. Lipopolysaccharides
(LPS) from E. coli (10 ng/ml; SIGMA) served as positive control.
The cells were stimulated by GAGs, oligosaccharides or LPS for
24 h at 37◦C, 5% CO2. The plates were centrifuged at ambient
temperature (200 g, 3min) and the supernatants were collected.
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Supernatants were stored at −20◦C upon use. Experiments
were carried out with five different batches of GAG and
GAG-oligosaccharides with a minimum of four blood donors.
The detection of IL-1Ra in the supernatants was carried out
using the DuoSet ELISA Kits (R&D Systems) according to the
manufacturers’ protocol. The supernatants were tested in a final
dilution of 1:33. The absorption at λ = 450 nm was measured
by the Tecan infinite M200Pro ELISA plate reader, while λ
= 570 nm served as a reference wavelength. In order to take
variable donor-dependent cytokine levels into account, induction
by GAG and GAG oligosaccharides were calculated as ratios to
induction by LPS: Cytokine levels induced by 10 ng/ml LPS were
set to 100% in each biological replicate and cytokine levels by
GAG or GAG oligosaccharides were estimated accordingly.
Detection of Cytotoxicity by Lactate
Dehydrogenase (LDH) Assay
Putative cytotoxicity of GAGs and GAG oligosaccharide was
estimated as LDH release from PBMCs. PMBCs were seeded in
a final concentration of 5 × 105 cells in 200 µl RPMI 1640 +
Glutamax-I supplemented with 10% human serum in a U-shape
96 well plate. GAGs and oligosaccharides were tested in a final
concentration 1.0 and 5.0µg/ml (amount according to MBTH
assay of hydrolyzed samples). Lipopolysaccharides (LPS) from E.
FIGURE 1 | De-N-acetylation of GAG. Degree of acetylation (DA) of GAGs (A).
DA was determined by an acetate assay (GAG, native polymer; dGAG,
de-N-acetylated) (B). In vitro IL-1Ra secretion in PBMC supernatants in
presence of GAG. LPS (10 ng/ml) served as external standard and were set to
100% in each biological replicate. Statistical analysis by WMW test in
comparison to GAG: ns, non significative; *p < 0.05; ***p < 0.001.
coli (10 ng/ml; SIGMA) served as negative control. Totally lysed
cells TritonX100 served as positive control and reference. All
supernatants were 1:5 diluted in PBS+ 1% BSA (positive control
1:20) and LDH assay was carried out by the LDH Cytotoxicity
Detection Kit (Roche) according to the manufacturer’s protocol.
None of these oligosaccharides were toxic to PBMCs (Figure S3),
showing that IL-1Ra secretion was not associated to cell apoptosis
or necrosis.
GAG and Oligo-GAG Application in
DSS-Treated Mice
DSS (Dextran sulfate sodium, 2.5% wt/vol, 36,000–50,000 kDa;
MP Biomedicals) was administered in drinking water ad libitum
for 7 days. Fresh solution was replaced on day 3. Mice were
injected intraperitoneally with 1 mg/kg of GAG samples for
7 consecutive days after DSS treatment. Weight loss, stool
consistency, and fecal blood were recorded daily. Upon necropsy,
tissues were collected for histology and cytokine analysis. Colonic
sections were stained with hematoxylin/eosin. Colitis disease
activity index was calculated daily for each mouse based on
weight loss, occult blood, and stool consistency. A score of 1–
4 was given for each parameter as in McNamee et al. (2011)
To evaluate cytokine production, colons, opened longitudinally
and washed in complete medium with antibiotics, were cultured
at 37◦C for 24 h in RPMI and 5% FBS. The supernatants were
collected for ELISA and the remaining colonic explant tissue
was homogenized and used for protein quantification (Quant-
iT Protein Assay Kit, Life Technologies). The concentration
of secreted cytokines in the supernatant was subsequently
normalized to total tissue protein and expressed as picogram of
cytokine per microgram of tissue. TNF-α, IL-1β, IL-17A, IL-17F,
IL-10, and IL-1Ra were measured in culture supernatants of 24 h
cultures using commercially available ELISAs (R&D systems)
according to the protocols supplied by the manufacturer.
STATISTICAL ANALYSIS
All experiments were performed with at least five different
batches of GAG and oligosaccharides and a minimum of four
blood donors. All statistics of in vitro experiments were carried
out with a two-tailed unpaired Wilcoxon–Mann–Whitney Test
by the free-of-charge software EDISON-WMW (Marx et al.,
2016). Statistical analyses from in vivo experiments (Figure 5)
were performed with one- or two-way ANOVA. Data, from one
experiment using 10 mice/group, were expressed as mean ± SD
and were analyzed in triplicate using GraphPad Prism Software.
P values are indicated by asterisk as follows: ∗p< 0.05; ∗∗p< 0.01;
∗∗∗p < 0.001.
ETHICAL STATEMENT
Murine experiments were performed according to the Italian
Approved Animal Welfare Authorization 360/2015-PR and
Legislative degree 26/2014 regarding the animal license obtained
by the ItalianMinistry of Health lasting for five years(2015-2020).
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RESULTS
Soluble Long α-1,4-Galactosamine
Oligomers (DP > 20) From GAG Induce
IL-1Ra on PBMCs
Whole GAG fractions, isolated from Brian culture supernatant
of A. fumigatus, were composed of galactose, galactosamine, and
N-acetylgalactosamine residues. A degree of acetylation (DA)
of galactosamine was determined to be 66 ± 7%, which is in
agreement with previous observations (Lee et al., 2016). To
further investigate the impact of the DA on IL-1Ra induction,
the GAG polymer was de-N-acetylated by a harsh alkali
treatment (4 h, 100◦C, 10M NaOH) (No and Meyers, 1989) to
produce a fully de-N-acetylated GAG (dGAG). GC analysis of
monosaccharide revealed that the galactose content in native
GAG (%Gal 8.3 ± 0.2%) was slightly reduced in dGAG (2.3
± 2.0%) (Figure S1). Both native GAG and dGAG induced IL-
1Ra in a concentration dependent manner to similar extent
(Figure 1). To produce and isolate soluble oligosaccharides of
different size, dGAG was hydrolyzed in 2M HCl for 1.5, 3, or
4.5 h at 100◦C. After the removal of acid by under vacuum,
water-soluble oligomers were recovered by centrifugation
and separated by size exclusion chromatography (SEC) on
a Superdex 30 column (Figure S1). While 1.5 h hydrolysis
mainly resulted in the production of larger oligosaccharides,
3 and 4.5 h hydrolysis times induced the release of small-size
oligosaccharides. Resulting of pooled oligomer fractions from the
three hydrolysates (fractions I-VIII) were analyzed by MALDI-
MS and GC (Figures S1, S4 and Figure 2A). Fractions V till
VII contained oligosaccharides till DP10 with the presence
of GalN and Gal residues and traces of glucose. Fractions II
to IV were characterized by higher MW oligosaccharides till
DP26 containing only GalN residues (Figure 2A and Figure S4).
Fraction I, composed also exclusively of GalN residues did not
give any ion peak by MALDI-TOF showing that this fraction
contained larger oligosaccharides (dp > 26). All these 8 fractions
were tested as putative IL-1Ra inducers (Figure 2B). Oligomers
of dp < 13 (Fractions IV to VIII) did not induce IL-1Ra
expression at the tested concentrations. A moderate activation
was observed for fraction III (13 < dp < 20) at the concentration
FIGURE 2 | Chemical analysis and IL-1Ra inducing activity of oligosaccharides generated by acid hydrolysis of dGAG. (A) Summerized MALDI-TOF MS analysis of
fractions I-VIII. (DP, degree of polymerization; for detailed MS spectra see Figure S2). (B) IL-1Ra production by dGAG oligosaccharides. dGAG oligosaccharides
fractions I-VIII were tested at 25, 5, and 1µg/ml. dGAG (5 and 1µg/ml) served as positive control. LPS (10 ng/ml) served as external standard and were set to 100%
in each biological replicate. Wilcoxon-Mann-Whitney Test: **p < 0.01; ***p < 0.001 (compared to control, M).
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of 25µg/ml, but not at lower concentration (5 and 1µg/ml).
Fractions I and II stimulated IL-1Ra production at 1 and 5µg/ml,
showing that galactose-free, de-N-acetylated oligosaccharides are
potential inducers. Fraction I induced IL-1Ra production at a
similar extend as the GAG native polymer showing that larger
were the soluble GalN oligosaccharides better was the production
of IL-1Ra.
Fractions I and II were subjected to an enzymatic degradation
with a recombinant endo-α-1,4-polygalactosaminidase
(GAGnase) from Pseudomonas sp. (see material and methods
for the production of the recombinant enzyme and Figure S2),
which specially hydrolyzed α-1,4-linked GalN polymers to
release GalN oligomers of DP 2 and 3, but does not use poly-
N-acetyl-galactosamine or other polysaccharides as substrate
(Tamura et al., 1988, 1992). Fractions I and II were degraded
by the recombinant GAGnase as determined by the release of
reducing ends (Figure 3A). Moreover, the hydrolyzed fractions
lost their ability to induce IL-1Ra secretion in PBMCs, showing
that only long α-1,4-GalN oligomers are inducers (Figure 3B).
The GAGnase protein neither activates nor inhibits IL-1Ra
expression at the desired concentration (Figure 3C).
Deacetylation of Galactosamine Oligomers
Is Essential to Induce the Production of
IL-1Ra
To test the impact of acetylation of GAG-oligosaccharides
on PBMC stimulation, GalN oligomers (fraction I to III)
were N-acetylated by acetic anhydride. After the acetylation
procedure, the per-N-acetylation and the absence of degradation
by GAGnase were confirmed by acetate assays (Figure 4A) and
MALDI-TOF-MS (Figure S5). A water-insoluble material was
observed in fractions I and II and but not in fraction III, showing
a decrease of solubility for the larger N-acetylated oligomers.
Most importantly, per-N-acetylated fractions I and II have lost
their capability to induce IL-1Ra (Figure 4B). A slight induction
of IL-1Ra was seen with the insoluble re-N-acetylated fraction I
which may be due to the presence of insoluble particles which
can induce unspecifically cytokine production (Becker et al.,
2016). Taking together, our data provided evidence that soluble
large GalN oligomers specifically triggered the IL-1Ra induction
in vitro.
Soluble Long De-N-Acetylated GAG
Oligomers Ameliorate Colitis in Dextran
Sulfate Sodium (DSS)-Treated Mice
To test the in vivo immunosuppressive potential of GAG
derivates, oligomers were tested in the experimental dextran
sulfate sodium (DSS)-induced colitis model in C57BL/6 mice
(Gresnigt et al., 2014). DSS treated mice lost over 25% body
weight, showed a reduced survival, an elevated DAI (disease
activity index) and colonic injury observed by macroscopic
imaging. Fractions I (>dp26) and III (13 < dp < 20) as well as
theirN-acetylated counterparts have been injected to DSS-treated
mice (Figure 5). Intraperitoneal injections of both versions of F-
I led to ameliorating the clinical signs of colitis by increasing
FIGURE 3 | IL-1Ra stimulation by GAG oligomers is abolished by GAGnase.
(A) Fraction F-I and F-II are degraded by GAGnase. Fractions I and II
(500µg/ml) were enzymatically hydrolyzed by GAGnase (2µg/ml) for 10 or
120min or were kept in acetate buffer for 120min (untreated). The degradation
was followed by PABA assay to quantify sugar reducing end. (B) Induction of
IL1-Ra expression in PBMCs by GAGnase treated fractions. (C) IL-1Ra
induction of PBMCs in presence of GAGnase (20 ng/µl). GAGnase neither
activate nor inhibit induction. LPS (10 ng/ml) served as reference control and
were set to 100% in each biological replicate. bars indicate the SD, WMW
Test: ***p < 0.001; ns, not significant (compared to control samples).
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FIGURE 4 | N-acetylation of de-N-acetylated GAG oligosaccharides and its
impact on the IL-1Ra production. (A) Determination of the degree of
acetylation (DA) by acetate assay of de-N-acetylated and acetylated fractions
I, II and III. GalN and GalNAc served as positive and negative controls. (B)
In vitro IL-1Ra production by de-N-acetylated and acetylated GAG fractions I,
II, and III (10 and 1µg/ml). LPS (10 ng/ml) served as positive control. WMW
Test: **p < 0.01, ***p < 0.001.
animal survival, reducing weight loss andDAI (Figure 5A), colon
size and histological alterations showing the amelioration of
colonic injury (Figure 5). Cytokine profile, such as a decrease
of IL-17A and IL-17F and increase of IL-1Ra, showed that the
deacetylated version (F-I) rescued DSS treated mice in a similar
way as the whole GAG polymer. In addition, F-I also promoted
IL-10, a cytokine known to be protective in colitis because IL-
10-deficient mice spontaneously develop enterocolitis and colon
cancer (Wang et al., 2015). The per-N-acetylated fraction I
(acF-I) did not induce IL-1Ra, suggesting that N-acetylated F-I
has a beneficial effect through an IL-1Ra independent pathway.
Acetylated and de-N-acetylated smaller oligosaccharides (acF-III
and F-III) showed opposite effects in vivo. IP injection of F-III
rescued the mice from death and the weight loss, ameliorated
DAI and strongly reduced inflammatory lesions (Figure 5). At
the cytokine level, F-III induced a similar pattern of cytokine
secretion as F-I with a decrease of pro-inflammatory cytokine
and increase of anti-inflammatory interleukins such as IL-10
and IL-1Ra (Figure 5D). Since F-III was a poor IL-1Ra inducer
in vitro (Figure 2B), our data suggested that the size of GalN
oligomers was less crucial in vivo than in vitro. In contrast,
the administration of the acetylated counterpart, acF-III, did
not rescue the inflammation where all colitis characteristics
(death, loss of weight, DAI, colon analysis, cytokine pattern) were
similar to those of DSS control mice (Figure 5). Even worse,
acF-III administration increase pro-inflammatory cytokines such
as TNFα, IL-1β, and IL-17 (Figure 5).
Taken together, data from Figure 5, two colitis rescue
profiles were observed with GAG oligomers. De-N-acetylated
oligomers (average dp of 16 or larger) rescued DSS-treated mice
with a significant reduction of inflammatory cells infiltration,
muscle thickening and amelioration of colonic structure. This
effect is concomitant to the induction of IL-1Ra secretion
as also observed in vitro. In contrast, insoluble acetylated
oligomers of dp > 26 rescued DSS-treated mice in a IL-1Ra-
independent mode of action. In summary, water-soluble poly-
galactosamine oligosaccharides are promising candidates for
alternative treatments of IL-1Ra-dependent diseases.
DISCUSSION
IL-1-mediated inflammation has been established in a broad
spectrum of diseases, ranging from rare autoinflammatory
diseases to common conditions such as gout and rheumatoid
arthritis, type 2 diabetes, atherosclerosis, and acute myocardial
infarction (Cavalli and Dinarello, 2018). The search for potent IL-
1 blockers to treat major inflammatory diseases has turned into a
very active field, which addresses several therapeutic approaches
(Finckh and Gabay, 2008; Gabay et al., 2010). Among them,
prevention of binding of active IL-1 on its cell surface receptors
by use of the recombinant form of IL-1Ra (Anakinra) offers an
ideal option as it has been used in several diseases (Dinarello et al.,
2012). Due to its anti-inflammatory potential, GAG produced
by A. fumigatus opens the way to novel innovative strategies
to control IL-1 signaling and to design new anti-inflammatory
drugs (Gresnigt et al., 2014). Here, to investigate the minimum
oligosaccharide sequences derived from GAG able to induce
anti-inflammatory response, partial chemical hydrolysis allowed
isolating soluble active oligomers. From our data, galactose is
not required for the bio-activity of GAG, in contrast, de-N-
acetylated GalN residues were essential to induce the secretion
of IL-1Ra both in vitro and in vivo. The size of oligomers plays
a critical function where a minimum size of 13 (and better >19)
α-1,4-GalN residues were required to be active in vitro. In vivo
experiments have confirmed the in vitro data and are able to
rescue inflammatory damage in a colitis model. Interestingly, the
poor in vitro inducer F-III has a similar in vivo beneficial effect
than larger oligomers, suggesting that the dose/size effect of GalN
oligomers is different in vitro and in vivo. The chemical synthesis
of defined GalN oligomers and in vivo kinetic studies will be
helpful to investigate the optimal size and the delivery of such
molecule in vivo.
The question of the chemical specificity of the IL-1Ra
inducers by cell wall polysaccharides is now fundamental. Cell
wall chitin and β-glucans are also IL-1Ra inducers (Poutsiaka
et al., 1993; Smeekens et al., 2015; Becker et al., 2016). β-
glucan structures remain essential to the IL-1Ra induction since
soluble forms are not inducers (Poutsiaka et al., 1993). This
result is in agreement with our data indicating the differential
immunological effect of soluble and insoluble polysaccharide
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FIGURE 5 | Reduced severity of DSS colitis in C57BL/6 mice treated with modified GAG molecules. DSS or water vehicle was administered ad libitum in drinking
water for 7 days. Native GAG polymer and GAG oligomers at the dose of 1 mg/kg were given intraperitoneally for 7 consecutive days after DSS treatment. (A)
Survival, weight (grams) and clinical disease activity index. (B) Macroscopic image of colons. (C) Histological assessment of colitis severity (20X magnification, bar =
200µm). (D) Levels of colonic cytokines. Data are expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****p < 0.0001 GAGs-treated vs. untreated (None)
C57BL/6 mice (n = 10 mice/group from one experiment). ns, not significant.
species. Moreover, β-glucans isolated from yeast or the hyphal
form of Candida albicans did not induce similar effects
(Smeekens et al., 2015) suggesting that small changes in the
chemical composition of the polysaccharides can modify the
immune response. Pure chitin isolated from A. fumigatus cell
wall induces IL-1Ra (Becker et al., 2016). Chitin is composed
of N-acetylglucosamine residues. However, in contrast to GAG,
it is the N-acetylated form of glucosamine residues that is
required for the IL-1Ra induction (Becker et al., 2016 and
data not shown). The seemingly contradictory literature on
the immunostimulatory properties of chitin are likely due
to many factors including differences in sources of material,
purity, readouts for inflammatory responses and the size of
particles. Large chitin particles strongly induce pro-inflammatory
response whereas small ones are not immunogenic (Alvarez,
2014). The degree of acetylation of cationic polysaccharides
such as chitosan is critical for the pro-inflammatory response,
showing that the de-N-acetylation of osamines not only alter
their physicochemical properties but also their immunological
activities (Bueter et al., 2011). The respective anti-inflammatory
and pro-inflammatory properties of N-acetylated F-III and de-N-
acetylated F-III are also an illustration (Figure 5). Chitin plays a
dual immune response depending of the purity: (1) pure chitin
induces an anti-inflammatory response in presence of serum and
(2) in presence of other PAMPs (LPS, muramyl dipeptide, but
not β-glucans), chitin has a synergistic effect on the induction
of pro-inflammatory cytokines in an independent pathway
(Becker et al., 2016), showing that the purity and homogeneity
of PAMP sample are extremely important to investigate
immune response.
β-Glucans induces both inflammatory and anti-inflammatory
response that are triggered through independent pathways. Two
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8 November 2019 | Volume 9 | Article 365
Gressler et al. Production of Anti-inflammatory GAG Oligomers
main PPRs, the C-type lectin Dectin-1 and the complement
receptor CR3 are known to recognize β-glucans (Brown and
Gordon, 2001; van Bruggen et al., 2009). In A.fumigatus the
pathway linking GAG to IL-1Ra production is unknown. IL-
1Ra induction by C. albicans β-glucans is dependent on a
Akt-PI3K dependent PRR (Smeekens et al., 2015). Our data
showed that insoluble and soluble GAG oligomers shared an
anti-inflammatory response with two independent pathways.
Insoluble oligomers may restore a protective effect in vivo on
colitis through an IL-1Ra independent pathway. In contrast,
soluble oligomers induce a specific induction of IL-1Ra where
the presence of de-N-acetylated galactosamine residues is
critical. Although the signaling pathway remains unknown,
it is independent on particle size or insolubility of polymer
as described for chitin and β-glucans. Our study showed
that soluble oligomers composed of an average of 16 α-
1,4-linked GalN residues display a specific IL-1Ra induction,
suggesting a specific immune pathway. Interestingly, pectin
macromolecules have gained significant attention partly because
of their immunosuppressive properties (Popov and Ovodov,
2013). Pectin induced in vitro a dose-dependent inhibition of
IL-1β secretion correlated to an increase secretion of anti-
inflammatory cytokines IL-10 and IL-1Ra by human PBMCs
(Salman et al., 2008). The anti-inflammatory properties are
dependent on a high content of α-1,4-linked galacturonic
acid in the main polysaccharidic chain (Popov and Ovodov,
2013). The structural comparison with GAG from A. fumigatus
suggests a structure-function relationship where linear α-1,4-
linked galactose derived monosaccharides may be important
for the anti-inflammatory properties of the polymer. However,
our data showed that GAG oligomers induce IL-1Ra in PBMCs
to a 20–100 fold extend in vivo and in vitro as compared to
pectin (Salman et al., 2008). α-1,4-GalN oligomers are highly
water-soluble alternatives to ease medically dose-response-
adjustments and to overcome application issues frequently
observed for insoluble chitin/chitosan polymers (Vo and Kim,
2014). Finally, our data suggest that the chemical synthesis of α-
1,4-GalN oligomers depict new tools to investigate the specific
immune pathway of GAG and provide a novel source of anti-
inflammatory glycodrugs for treatment of IL-1-driven diseases.
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